Conservation of epigenetic regulation by the MLL3/4 tumour suppressor in planarian pluripotent stem cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Conservation of epigenetic regulation by the MLL3/4 tumour suppressor in planarian pluripotent stem cells ; volume:9 ; number:1 ; day:7 ; month:9 ; year:2018 ; pages:1-17 ; date:12.2018
Nature Communications ; 9, Heft 1 (7.9.2018), 1-17, 12.2018
- Klassifikation
-
Biowissenschaften, Biologie
- Urheber
-
Mihaylova, Yuliana
- Beteiligte Personen und Organisationen
-
Abnave, Prasad
Kao, Damian
Hughes, Samantha
Lai, Alvina
Jaber-Hijazi, Farah
Kosaka, Nobuyoshi
Aboobaker, A. Aziz
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-06092-6
- URN
-
urn:nbn:de:101:1-2018103120515798198424
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mihaylova, Yuliana
- Abnave, Prasad
- Kao, Damian
- Hughes, Samantha
- Lai, Alvina
- Jaber-Hijazi, Farah
- Kosaka, Nobuyoshi
- Aboobaker, A. Aziz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids
Regulation of the NF2 tumour suppressor Merlin
Epigenetic Biomarker to Support Classification into Pluripotent and Non-Pluripotent Cells
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Computational identification of tumour suppressor protein p53 target genes
Epigenetic differences between naïve and primed pluripotent stem cells
Epigenetic biomarkers to track differentiation of pluripotent stem cells
The tumour suppressor p53 as a supporter of DNA replication
Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids
Regulation of the NF2 tumour suppressor Merlin
Epigenetic Biomarker to Support Classification into Pluripotent and Non-Pluripotent Cells
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Computational identification of tumour suppressor protein p53 target genes
Epigenetic differences between naïve and primed pluripotent stem cells
Epigenetic biomarkers to track differentiation of pluripotent stem cells
The tumour suppressor p53 as a supporter of DNA replication
Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function
Understanding p53 tumour suppressor network
Understanding p53 tumour suppressor network
Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids
Regulation of the NF2 tumour suppressor Merlin
Epigenetic Biomarker to Support Classification into Pluripotent and Non-Pluripotent Cells
Degradation of tumour suppressor ρ53 during Chlamydia trachomatis infections
Degradation of Tumour Suppressor p53 during Chlamydia trachomatis Infections
Computational identification of tumour suppressor protein p53 target genes
Epigenetic differences between naïve and primed pluripotent stem cells
Epigenetic biomarkers to track differentiation of pluripotent stem cells